Your session is about to expire
← Back to Search
Behavioural Intervention
Positive Peers App for HIV (PoPIT Trial)
N/A
Recruiting
Led By Ann Avery, MD
Research Sponsored by MetroHealth Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if using the Positive Peers mobile app can help young individuals (aged 13-34) with HIV achieve better viral suppression. Participants will download the app on their phones,
Who is the study for?
This trial is for young people aged 13-34 with HIV, particularly from minority groups. Participants need to have a personal smartphone to download and use the Positive Peers mobile app and be willing to complete online surveys over a year at specified intervals.
What is being tested?
The study is testing whether the Positive Peers mobile app can help increase rates of viral suppression in participants. It also aims to identify user characteristics linked with better health outcomes, retention in care, and reduced perceived stigma related to HIV.
What are the potential side effects?
Since this intervention involves using an app rather than medication or medical procedures, traditional side effects are not expected. However, users may experience increased screen time which could affect sleep patterns or eye strain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Viral suppression
Secondary study objectives
Correlates of app use and HIV related perceived stigma
Correlates of app use and retention in care
Correlates of app use and viral suppression
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Immediate StartExperimental Treatment1 Intervention
Participants in the immediate start arm will download and begin use of the Positive Peers app at the enrollment visit.
Group II: Observational CohortActive Control1 Intervention
Participants in the observational cohort have declined participation in the clinical trial but agree to do the baseline survey and have medical outcomes data recorded.
Group III: Delayed StartActive Control1 Intervention
Participants in the delayed start arm will download and begin use of the Positive Peers app 6 months after enrollment
Find a Location
Who is running the clinical trial?
Kent State UniversityOTHER
43 Previous Clinical Trials
6,639 Total Patients Enrolled
MetroHealth Medical CenterLead Sponsor
117 Previous Clinical Trials
21,237 Total Patients Enrolled
Ann Avery, MDPrincipal InvestigatorMetroHealth/ CWRU
1 Previous Clinical Trials
105 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger